{"id":"https://openalex.org/W2135340562","doi":"https://doi.org/10.1200/jco.2010.28.5791","title":"Personalizing Therapy for Ovarian Cancer: BRCAness and Beyond","display_name":"Personalizing Therapy for Ovarian Cancer: BRCAness and Beyond","publication_year":2010,"publication_date":"2010-06-15","ids":{"openalex":"https://openalex.org/W2135340562","doi":"https://doi.org/10.1200/jco.2010.28.5791","mag":"2135340562","pmid":"https://pubmed.ncbi.nlm.nih.gov/20547987"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.5791","doi":"https://doi.org/10.1200/jco.2010.28.5791","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.5791","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067595997","display_name":"Robert C. Bast","orcid":"https://orcid.org/0000-0003-4621-8462","observed_orcids":["https://orcid.org/0000-0003-4621-8462"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert C. Bast","raw_affiliation_strings":["The University of Texas M. D. Anderson Cancer Center, Houston, TX","Experimental Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Experimental Therapeutics","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005221518","display_name":"Gordon Brent Mills","orcid":"https://orcid.org/0000-0002-0144-9614","observed_orcids":["https://orcid.org/0000-0002-0144-9614"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gordon B. Mills","raw_affiliation_strings":["The University of Texas M. D. Anderson Cancer Center, Houston, TX","Systems Biology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Systems Biology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":62,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"22","first_page":"3545","last_page":"3548"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.01510000042617321,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.8539999723434448},{"id":"https://openalex.org/keywords/brcaness","display_name":"BRCAness","score":0.847000002861023},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.8500000238418579},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9570000171661377},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.7120000123977661},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.5370000004768372},{"id":"https://openalex.org/keywords/personalized-treatment","display_name":"personalized treatment","score":0.699999988079071},{"id":"https://openalex.org/keywords/brca1-promoter-methylation","display_name":"BRCA1 promoter methylation","score":0.8920000195503235},{"id":"https://openalex.org/keywords/germline-mutations","display_name":"germline mutations","score":0.5569999814033508},{"id":"https://openalex.org/keywords/sporadic-ovarian-cancer","display_name":"sporadic ovarian cancer","score":0.7200000286102295},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.4860000014305115},{"id":"https://openalex.org/keywords/chemotherapy-response","display_name":"chemotherapy response","score":0.34599998593330383},{"id":"https://openalex.org/keywords/survival-outcomes","display_name":"survival outcomes","score":0.4580000042915344},{"id":"https://openalex.org/keywords/brca1-2-mutation-carriers","display_name":"BRCA1/2 mutation carriers","score":0.49799999594688416},{"id":"https://openalex.org/keywords/base-excision-repair","display_name":"base excision repair","score":0.6100000143051147},{"id":"https://openalex.org/keywords/double-strand-break-repair","display_name":"DNA double-strand break repair","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.8187171220779419},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7933043241500854},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.6888448596000671},{"id":"https://openalex.org/C2780194787","wikidata":"https://www.wikidata.org/wiki/Q4836333","display_name":"BRCA mutation","level":4,"score":0.6677638292312622},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.5583658218383789},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5565620064735413},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.5287266373634338},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48693883419036865},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4868721067905426},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.47158730030059814},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.42918381094932556},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42907050251960754},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.41557109355926514},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.31203562021255493},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.27692747116088867},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1483963429927826},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13650214672088623},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.13584035634994507},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.09409785270690918}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011065","descriptor_name":"Poly(ADP-ribose) Polymerases","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019398","descriptor_name":"Genes, BRCA1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024522","descriptor_name":"Genes, BRCA2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2010.28.5791","doi":"https://doi.org/10.1200/jco.2010.28.5791","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.5791","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:20547987","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20547987","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Comment"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2149024233","display_name":"MD Anderson Gynecologic SPORE for Uterine Cancers","funder_award_id":"P50CA098258","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W6320432","https://openalex.org/W1863225814","https://openalex.org/W1976564360","https://openalex.org/W1994563300","https://openalex.org/W1998258610","https://openalex.org/W2051000382","https://openalex.org/W2055727982","https://openalex.org/W2059000312","https://openalex.org/W2088561077","https://openalex.org/W2090968329","https://openalex.org/W2091739733","https://openalex.org/W2096521047","https://openalex.org/W2097105130","https://openalex.org/W2105651363","https://openalex.org/W2122205071","https://openalex.org/W2129825215","https://openalex.org/W2142795777","https://openalex.org/W2154885792","https://openalex.org/W2156077962","https://openalex.org/W2160234594","https://openalex.org/W2167692560","https://openalex.org/W2171916754","https://openalex.org/W2171972386","https://openalex.org/W2171999860","https://openalex.org/W2272392241","https://openalex.org/W2328421677"],"related_works":["https://openalex.org/W2130541818","https://openalex.org/W2790899000","https://openalex.org/W4365509877","https://openalex.org/W4311484871","https://openalex.org/W2520031340","https://openalex.org/W3011368562","https://openalex.org/W1985506319","https://openalex.org/W2157853274","https://openalex.org/W4390955140","https://openalex.org/W2099080114"],"abstract_inverted_index":{"Although":[0,741],"70%":[1],"to":[2,9,60,95,99,126,149,178,196,254,274,324,336,343,382,419,426,435,439,526,537,547,646,704,775],"80%":[3],"of":[4,14,48,58,80,138,145,151,159,169,198,219,227,256,265,282,291,302,326,345,351,355,362,377,400,447,475,488,540,552,557,593,624,668,673,686,717,729,744,767,778],"epithelial":[5,347,402],"ovarian":[6,40,110,155,244,260,283,294,328,348,403,428,586,614,633],"cancers":[7,247,429,634,733],"respond":[8],"chemotherapy,":[10],"less":[11,660],"than":[12,76,312],"30%":[13],"patients":[15,38,133,285,410,437,620,636,676],"can":[16,371,390,652],"be":[17,309,465],"cured":[18],"with":[19,23,39,134,224,234,286,405,430,480,621,637,691,734,751,761,780],"cytoreductive":[20],"surgery":[21],"combined":[22],"the":[24,30,34,46,49,91,146,165,176,373,392,406,457,460,468,472,510,541,555,591,594,606,666,674,679,705,742,755,765,769],"best":[25,147],"currently":[26],"available":[27],"drugs.":[28],"Over":[29],"last":[31],"three":[32],"decades,":[33],"median":[35],"survival":[36,50,75],"for":[37,154,580,590],"cancer":[41,111,160,191,261,284,706],"has":[42,52,333,357,535],"improved":[43],"significantly,":[44],"but":[45,279],"plateau":[47],"curve":[51],"not":[53,523],"changed":[54],"appreciably.":[55],"Empirical":[56],"combinations":[57],"up":[59,323],"five":[61],"individually":[62],"active":[63],"drugs":[64,114],"have":[65,142,319],"proven":[66],"no":[67],"more":[68,310],"effective":[69,93],"in":[70,107,120,132,162,182,222,243,322,341,360,395,433,467,491,509,582,656,665,678,695,727],"extending":[71],"disease-free":[72],"or":[73,140,171,267,375,529,544,559,565,626,639,725,736,739],"overall":[74],"a":[77,207,235,277,287,398,421,502,549,577,715],"two-drug":[78],"combination":[79],"carboplatin":[81],"and":[82,112,216,229,245,248,293,304,316,368,387,423,514,519,584,630],"paclitaxel.":[83],"In":[84,188,570,628,671],"this":[85,189,571,629],"setting,":[86,190],"many":[87],"investigators":[88],"believe":[89],"that":[90,105,115,121,209,300,380,408,459,658,698],"most":[92],"strategy":[94],"improve":[96],"outcomes":[97],"is":[98,173,450,501,746,773],"personalize":[100],"therapy,":[101],"targeting":[102],"those":[103],"abnormalities":[104],"occur":[106],"each":[108],"individual":[109],"avoiding":[113],"will":[116,464,484],"cause":[117],"excessive":[118],"toxicity":[119],"particular":[122,527],"patient.":[123],"Striking":[124],"responses":[125],"poly(adenosine":[127],"diphosphate-ribose)":[128],"polymerase":[129],"(PARP)":[130],"inhibitors":[131,197,221,270],"inactivating":[135,366],"germline":[136,225,263,622,641],"mutations":[137,226,264,318,367,521,623,642,694],"BRCA1":[139,170,228,266,303,315,330,339,513,625,638,738,779],"BRCA2":[141,172,230,317,515,640,762],"provided":[143],"one":[144],"examples":[148],"date":[150],"personalized":[152],"therapy":[153],"cancer.":[156,295],"During":[157],"transformation":[158],"cells":[161,192],"mutation":[163],"carriers,":[164],"second":[166],"functional":[167],"allele":[168],"lost,":[174],"inhibiting":[175],"ability":[177],"repair":[179,201],"double-strand":[180,654],"breaks":[181,655],"DNA":[183,200,489,657],"through":[184],"homologous":[185],"recombination":[186],"(HR).":[187],"are":[193,231,507,516,659],"selectively":[194],"sensitized":[195],"other":[199,378,481,631],"pathways,":[202],"including":[203],"base":[204],"excision":[205],"repair,":[206],"process":[208],"requires":[210],"PARP.":[211],"Data":[212],"from":[213,413,441,612,618,635,732],"phase":[214],"I":[215,789,793],"II":[217],"trials":[218],"PARP":[220,269,414,442],"women":[223,257],"quite":[232],"promising,":[233],"40%":[236],"objective":[237],"response":[238],"rate":[239],"as":[240,714],"single":[241],"agents":[242,651],"breast":[246,292],"acceptable":[249],"toxicity.":[250],"Because":[251],"only":[252,276],"10%":[253],"15%":[255],"who":[258],"develop":[259,420],"carry":[262],"BRCA2,":[268,305,356],"were":[271,759],"initially":[272],"expected":[273],"benefit":[275,412,440],"small,":[278,747],"important,":[280],"subset":[281],"strong":[288],"family":[289],"history":[290],"However,":[296],"recent":[297],"data":[298],"suggest":[299],"dysfunction":[301,777],"so-called":[306],"BRCAness,":[307],"may":[308],"prevalent":[311],"originally":[313],"assumed.":[314],"been":[320,334,358,536],"found":[321],"20%":[325],"unselected":[327],"cancers.":[329,349,476,587],"promoter":[331,369],"methylation":[332,370,490],"reported":[335],"markedly":[337],"decrease":[338],"expression":[340,376,563],"5%":[342],"31%":[344],"sporadic":[346,363,585],"Amplification":[350],"EMSY,":[352],"an":[353],"inhibitor":[354,443],"observed":[359,760],"17%":[361],"cases.":[364],"Furthermore,":[365],"disrupt":[372],"function":[374,703],"genes":[379,506,697],"contribute":[381],"HR.":[383],"Thus,":[384],"both":[385],"genetic":[386,543],"epigenetic":[388,545],"mechanisms":[389],"create":[391],"BRCAness":[393,431,498,553,581,607],"phenotype":[394],"at":[396,554],"least":[397],"third":[399],"all":[401],"cancers,":[404,615],"expectation":[407,458],"these":[409,650],"would":[411],"inhibitors.":[415],"The":[416,445,719],"challenge":[417,463,503],"remains":[418],"convenient":[422],"accurate":[424],"method":[425],"identify":[427,436,548],"and,":[432],"particular,":[434],"likely":[438],"therapy.":[444],"cost":[446],"high-throughput":[448],"sequencing":[449,474,479,500],"being":[451],"halved":[452],"every":[453],"6":[454],"months,":[455],"supporting":[456],"thousand-dollar":[461],"genome":[462],"fulfilled":[466],"near":[469],"future,":[470],"permitting":[471],"cost-effective":[473],"Coupling":[477],"next-generation":[478],"analytic":[482],"approaches":[483],"also":[485],"make":[486],"measurement":[487],"multiple":[492,505],"promoters":[493],"practical.":[494],"At":[495],"present,":[496],"judging":[497],"by":[499,663,681],"because":[504,649],"involved":[508],"HR":[511,664,702],"pathway,":[512],"large":[517],"genes,":[518],"somatic":[520],"do":[522],"seem":[524],"limited":[525],"nucleotides":[528],"hot":[530],"spots.":[531],"An":[532],"alternative":[533],"approach":[534],"look":[538],"downstream":[539],"fundamental":[542],"changes":[546],"distinctive":[550],"signature":[551,579,595,721,772],"level":[556],"mRNAs":[558],"proteins,":[560],"using":[561,598],"gene":[562],"arrays":[564,568],"reverse-phase":[566],"protein":[567],"(RRPAs).":[569],"issue,":[572],"Konstantinopoulos":[573,682],"et":[574,683],"al":[575],"report":[576,680],"60-gene":[578,770],"familial":[583],"Preliminary":[588],"evidence":[589],"validity":[592],"was":[596,689],"sought":[597],"several":[599],"different":[600],"approaches.":[601],"Initially,":[602],"they":[603],"determined":[604],"whether":[605,768],"profile":[608],"could":[609],"distinguish":[610],"platinum-sensitive":[611],"platinum-resistant":[613],"profiling":[616],"biopsies":[617,731],"six":[619,675],"BRCA2.":[627,740],"studies,":[632],"exhibit":[643],"greater":[644,781],"sensitivity":[645,713,724],"platinum":[647,687,712,723,748],"compounds":[648],"induce":[653],"readily":[661],"repaired":[662],"presence":[667],"BRCA":[669,696,752],"dysfunction.":[670],"four":[672],"studied":[677],"al,":[684],"emergence":[685],"resistance":[688,726,749],"associated":[690],"additional":[692],"revertant":[693,737],"presumably":[699],"restored":[700],"normal":[701],"cells.":[707],"This":[708],"observation":[709],"strongly":[710],"supports":[711],"predictor":[716],"BRCAness.":[718],"BRCA-like":[720,771],"predicted":[722],"eight":[728],"10":[730],"mutated":[735],"number":[743],"cases":[745],"correlated":[750],"status.":[753],"Interestingly,":[754],"two":[756],"discordant":[757],"results":[758],"mutations,":[763],"raising":[764],"question":[766],"able":[774],"detect":[776],"accuracy.":[782],"JOURNAL":[783],"OF":[784],"CLINICAL":[785],"ONCOLOGY":[786],"E":[787],"D":[788],"T":[790],"O":[791],"R":[792],"A":[794],"L":[795],"S":[796],"VOLUME":[797],"28":[798],"NUMBER":[799],"22":[800],"AUGUST":[801],"1":[802],"2010":[803]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}